AU2002361185A1 - Use of (+)-(1s,2s)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol as anti-emetic agent - Google Patents
Use of (+)-(1s,2s)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol as anti-emetic agentInfo
- Publication number
- AU2002361185A1 AU2002361185A1 AU2002361185A AU2002361185A AU2002361185A1 AU 2002361185 A1 AU2002361185 A1 AU 2002361185A1 AU 2002361185 A AU2002361185 A AU 2002361185A AU 2002361185 A AU2002361185 A AU 2002361185A AU 2002361185 A1 AU2002361185 A1 AU 2002361185A1
- Authority
- AU
- Australia
- Prior art keywords
- dimethylamino
- phenol
- propyl
- ethyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10163421A DE10163421A1 (en) | 2001-12-21 | 2001-12-21 | Use of (+) - (1S, 2S) -3- (3-dimethylamino-1-ethyl-2-methyl-propyl) phenol as an anti-emetic |
DE10163421.8 | 2001-12-21 | ||
PCT/EP2002/014636 WO2003053427A1 (en) | 2001-12-21 | 2002-12-20 | Use of (+)-(1s,2s)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol as anti-emetic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002361185A1 true AU2002361185A1 (en) | 2003-07-09 |
Family
ID=7710471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002361185A Abandoned AU2002361185A1 (en) | 2001-12-21 | 2002-12-20 | Use of (+)-(1s,2s)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol as anti-emetic agent |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002361185A1 (en) |
DE (1) | DE10163421A1 (en) |
WO (1) | WO2003053427A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005013726A1 (en) * | 2005-03-22 | 2006-09-28 | Grünenthal GmbH | Transdermal therapeutic system for transdermal application of opioid containing analgesics, especially using a plaster for application to permit long-term, pain-free application |
AU2014202535B2 (en) * | 2010-03-11 | 2016-05-26 | Acacia Pharma Limited | The use of amisulpride as an anti-emetic |
AU2016216578B2 (en) * | 2010-03-11 | 2017-11-23 | Acacia Pharma Limited | The use of amisulpride as an anti-emetic |
GB201004020D0 (en) | 2010-03-11 | 2010-04-21 | Acacia Pharma Ltd | New therapeutic use |
JP6133772B2 (en) * | 2010-06-15 | 2017-05-24 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Pharmaceutical formulation for pain treatment |
EP3300726A1 (en) * | 2011-07-29 | 2018-04-04 | Grünenthal GmbH | Intrathecal or epidural administration of 3-[(1s,2s)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4426245A1 (en) * | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-phenyl-3-dimethylamino-propane compounds with pharmacological activity |
DE10109763A1 (en) * | 2001-02-28 | 2002-09-05 | Gruenenthal Gmbh | Pharmaceutical salts |
-
2001
- 2001-12-21 DE DE10163421A patent/DE10163421A1/en not_active Withdrawn
-
2002
- 2002-12-20 AU AU2002361185A patent/AU2002361185A1/en not_active Abandoned
- 2002-12-20 WO PCT/EP2002/014636 patent/WO2003053427A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE10163421A1 (en) | 2003-07-31 |
WO2003053427A1 (en) | 2003-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004105722A8 (en) | A formulation for chemical peeling | |
AU2002332019A1 (en) | Adjuvant compositions | |
AU2002359163A1 (en) | New use | |
AU2002360759A1 (en) | Polyether carbamate compounds, compositions containing such compounds, and methods related thereto | |
AU2002353132A1 (en) | Resveratrol analogues | |
NO20034527D0 (en) | 3,7-diazabicyclo (3,3,1) formulations as antiarrhythmic compounds | |
AU2002334406A1 (en) | Polishing composition | |
AU2002361185A1 (en) | Use of (+)-(1s,2s)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol as anti-emetic agent | |
AU2002322326A1 (en) | Tolterodine metabolites | |
AU2002359914A1 (en) | Blade sharpener | |
AU2002307456A1 (en) | Resource localization | |
AU2002331972A1 (en) | 3,4-methylenedioxy-substituted chalcones as therapeutic agents | |
NO20034528D0 (en) | 3,7-diazabicyclo (3,3,1) formulations as antiarrhythmic compounds | |
AU2002356930A1 (en) | Partially fluorinated naphthyl-based borates | |
AU2001250279A1 (en) | Use of naphthindazole-4,9-quinones as antiparasitic agents | |
AU2002364178A1 (en) | Ownership of part-physical, part-virtual devices | |
AU2002252646A1 (en) | Cyclohexylphenyl vasopressin agonists | |
AU2002338757A1 (en) | Method for finding novel active ingredients having androgen-type properties | |
AU2002361987A1 (en) | Substituted beta-aminoalcohols used as medicaments | |
AU2002329500A1 (en) | New sulfonamide derivatives as d3-receptor agonists | |
AU2002313470A1 (en) | Formulation containing halofantrine hydrochloride | |
AU2002238736A1 (en) | Anaesthetic formulation comprising articaine | |
AU2002228465A1 (en) | Finishing agent | |
AU2002244943A1 (en) | Remedies for vesical hyperactivity | |
AU2002317385A1 (en) | Compounds for use as surfactants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |